ReviewFrontiers in public health2026
Dissemination and implementation science for global ophthalmology: closing the last-mile translational gap.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite remarkable advances in ophthalmic diagnostics and therapeutics over the past decade, the global prevalence of avoidable visual impairment and blindness has remained unchanged. This paradox reflects a crisis of care delivery and the persistent failure to consistently, equitably, and effectively translate evidence-based interventions into routine practice for the millions who need them most. Dissemination and implementation (D&I) science offers ophthalmology rigorous, evidence-informed frameworks to close this last-mile translational gap. Drawing on the established body of D&I science theory, methods, and applications, this review argues that ophthalmology has been slow to harness these tools, and that doing so now is imperative. We examine the current evidence for D&I science applications across key domains of global eye care: equitable care delivery in the US, global eye health in low- and middle-SDI regions, gender equity, and the implementation of artificial intelligence-based diagnostic tools. Across each domain, we identify both promising examples of D&I science in action and critical gaps in evidence, equity, and sustainability. Achieving vision health equity worldwide will require ophthalmology to treat the dissemination, implementation, and sustainment of evidence-based eye care as central to its mission as the development of the innovations themselves.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.